A detailed history of Perigon Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Perigon Wealth Management, LLC holds 18,632 shares of NVO stock, worth $1.63 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
18,632
Previous 18,701 0.37%
Holding current value
$1.63 Million
Previous $2.67 Million 16.9%
% of portfolio
0.06%
Previous 0.08%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$119.07 - $145.42 $8,215 - $10,033
-69 Reduced 0.37%
18,632 $2.22 Million
Q2 2024

Aug 02, 2024

BUY
$122.71 - $146.91 $13,252 - $15,866
108 Added 0.58%
18,701 $2.67 Million
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $656,363 - $873,693
6,428 Added 52.84%
18,593 $2.39 Million
Q4 2023

Jan 29, 2024

BUY
$87.78 - $105.45 $421,168 - $505,949
4,798 Added 65.13%
12,165 $1.26 Million
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $367,306 - $805,942
4,039 Added 121.36%
7,367 $669,000
Q2 2023

Aug 02, 2023

BUY
$155.98 - $172.65 $160,659 - $177,829
1,030 Added 44.82%
3,328 $538,000
Q1 2023

May 03, 2023

SELL
$132.34 - $159.14 $27,526 - $33,101
-208 Reduced 8.3%
2,298 $365,000
Q4 2022

Feb 14, 2023

SELL
$102.55 - $135.33 $9,947 - $13,127
-97 Reduced 3.73%
2,506 $339,000
Q3 2022

Dec 13, 2022

BUY
$95.28 - $116.93 $7,622 - $9,354
80 Added 3.17%
2,603 $259,000
Q2 2022

Aug 11, 2022

BUY
$103.24 - $121.81 $260,474 - $307,326
2,523 New
2,523 $281,000
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $45,600 - $51,557
-680 Closed
0 $0
Q4 2020

Jan 28, 2021

BUY
$63.89 - $73.8 $43,445 - $50,184
680 New
680 $47,000
Q2 2018

Aug 07, 2018

SELL
$44.29 - $50.42 $23,252 - $26,470
-525 Closed
0 $0
Q2 2017

Sep 12, 2017

BUY
N/A
525 New
525 $23,000
Q3 2011

Nov 14, 2022

BUY
N/A
80
2,603 $259,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Perigon Wealth Management, LLC Portfolio

Follow Perigon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perigon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perigon Wealth Management, LLC with notifications on news.